Click for best price
Systemic Psoriasis Therapeutics Market Size, Share 2023
| Market size in 2022 |
US$ 12060 million
|
Forecast Market size by 2029 |
US$ 19640 million
|
| Growth Rate |
CAGR of 7.2% |
Number of Pages |
69 Pages |
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
This report aims to provide a comprehensive presentation of the global market for Systemic Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Psoriasis Therapeutics. This report contains market size and forecasts of Systemic Psoriasis Therapeutics in global, including the following market information:
Global Systemic Psoriasis Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Systemic Psoriasis Therapeutics market was valued at US$ 12060 million in 2022 and is projected to reach US$ 19640 million by 2029, at a CAGR of 7.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.
We surveyed the Systemic Psoriasis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Psoriasis Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Systemic Psoriasis Therapeutics Market Segment Percentages, by Type, 2022 (%)
Biologics
Small Molecules
Global Systemic Psoriasis Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Systemic Psoriasis Therapeutics Market Segment Percentages, by Application, 2022 (%)
Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis
Global Systemic Psoriasis Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Systemic Psoriasis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Psoriasis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Systemic Psoriasis Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Johnson & Johnson
Celgene
Amgen
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Systemic Psoriasis Therapeutics, market overview.
Chapter 2: Global Systemic Psoriasis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Systemic Psoriasis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Systemic Psoriasis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Systemic Psoriasis Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 12060 million
|
| Forecast Market size by 2029 |
US$ 19640 million
|
| Growth Rate |
CAGR of 7.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Systemic Psoriasis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Systemic Psoriasis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Systemic Psoriasis Therapeutics Overall Market Size
2.1 Global Systemic Psoriasis Therapeutics Market Size: 2022 VS 2029
2.2 Global Systemic Psoriasis Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Systemic Psoriasis Therapeutics Players in Global Market
3.2 Top Global Systemic Psoriasis Therapeutics Companies Ranked by Revenue
3.3 Global Systemic Psoriasis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Systemic Psoriasis Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Systemic Psoriasis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Systemic Psoriasis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Systemic Psoriasis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Systemic Psoriasis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Systemic Psoriasis Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Biologics
4.1.3 Small Molecules
4.2 By Type - Global Systemic Psoriasis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Systemic Psoriasis Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Systemic Psoriasis Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Systemic Psoriasis Therapeutics Market Size, 2022 & 2029
5.1.2 Mild Psoriasis
5.1.3 Moderate Psoriasis
5.1.4 Severe Psoriasis
5.2 By Application - Global Systemic Psoriasis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Systemic Psoriasis Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Systemic Psoriasis Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Systemic Psoriasis Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Systemic Psoriasis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Systemic Psoriasis Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Systemic Psoriasis Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Systemic Psoriasis Therapeutics Revenue, 2018-2029
6.3.2 US Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.3.3 Canada Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.3.4 Mexico Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Systemic Psoriasis Therapeutics Revenue, 2018-2029
6.4.2 Germany Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4.3 France Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4.4 U.K. Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4.5 Italy Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4.6 Russia Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.4.8 Benelux Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Systemic Psoriasis Therapeutics Revenue, 2018-2029
6.5.2 China Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.5.3 Japan Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.5.4 South Korea Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.5.6 India Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Systemic Psoriasis Therapeutics Revenue, 2018-2029
6.6.2 Brazil Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.6.3 Argentina Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Systemic Psoriasis Therapeutics Revenue, 2018-2029
6.7.2 Turkey Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.7.3 Israel Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Systemic Psoriasis Therapeutics Market Size, 2018-2029
6.7.5 UAE Systemic Psoriasis Therapeutics Market Size, 2018-2029
7 Systemic Psoriasis Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Systemic Psoriasis Therapeutics Major Product Offerings
7.1.4 AbbVie Systemic Psoriasis Therapeutics Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Major Product Offerings
7.2.4 Johnson & Johnson Systemic Psoriasis Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Systemic Psoriasis Therapeutics Major Product Offerings
7.3.4 Celgene Systemic Psoriasis Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Celgene Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Systemic Psoriasis Therapeutics Major Product Offerings
7.4.4 Amgen Systemic Psoriasis Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Systemic Psoriasis Therapeutics Major Product Offerings
7.5.4 Pfizer Systemic Psoriasis Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Systemic Psoriasis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Systemic Psoriasis Therapeutics Market Drivers in Global Market
Table 3. Systemic Psoriasis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Systemic Psoriasis Therapeutics in Global Market
Table 5. Top Systemic Psoriasis Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Systemic Psoriasis Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Systemic Psoriasis Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Systemic Psoriasis Therapeutics Product Type
Table 9. List of Global Tier 1 Systemic Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Systemic Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Systemic Psoriasis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Systemic Psoriasis Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Systemic Psoriasis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Systemic Psoriasis Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Systemic Psoriasis Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Systemic Psoriasis Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Systemic Psoriasis Therapeutics Product Offerings
Table 32. AbbVie Systemic Psoriasis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Systemic Psoriasis Therapeutics Product Offerings
Table 36. Johnson & Johnson Systemic Psoriasis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Celgene Company Summary
Table 39. Celgene Systemic Psoriasis Therapeutics Product Offerings
Table 40. Celgene Systemic Psoriasis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Key News & Latest Developments
Table 42. Amgen Company Summary
Table 43. Amgen Systemic Psoriasis Therapeutics Product Offerings
Table 44. Amgen Systemic Psoriasis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Amgen Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Systemic Psoriasis Therapeutics Product Offerings
Table 48. Pfizer Systemic Psoriasis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Systemic Psoriasis Therapeutics Segment by Type in 2022
Figure 2. Systemic Psoriasis Therapeutics Segment by Application in 2022
Figure 3. Global Systemic Psoriasis Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Systemic Psoriasis Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Systemic Psoriasis Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2022
Figure 8. By Type - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Systemic Psoriasis Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Systemic Psoriasis Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Amgen Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Systemic Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
